Suppr超能文献

氧化应激控制调节性T细胞凋亡、抑制活性以及肿瘤中程序性死亡配体1(PD-L1)阻断抗性。

Oxidative stress controls regulatory T cell apoptosis and suppressor activity and PD-L1-blockade resistance in tumor.

作者信息

Maj Tomasz, Wang Wei, Crespo Joel, Zhang Hongjuan, Wang Weimin, Wei Shuang, Zhao Lili, Vatan Linda, Shao Irene, Szeliga Wojciech, Lyssiotis Costas, Liu J Rebecca, Kryczek Ilona, Zou Weiping

机构信息

Department of Surgery, University of Michigan School of Medicine, Ann Arbor, Michigan, USA.

Department of Immunology and Key Laboratory of Medical Immunology of the Ministry of Public Health, School of Basic Medical Sciences, Peking University Health Science Center, Beijing, China.

出版信息

Nat Immunol. 2017 Dec;18(12):1332-1341. doi: 10.1038/ni.3868. Epub 2017 Oct 30.

Abstract

Live regulatory T cells (T cells) suppress antitumor immunity, but how T cells behave in the metabolically abnormal tumor microenvironment remains unknown. Here we show that tumor T cells undergo apoptosis, and such apoptotic T cells abolish spontaneous and PD-L1-blockade-mediated antitumor T cell immunity. Biochemical and functional analyses show that adenosine, but not typical suppressive factors such as PD-L1, CTLA-4, TGF-β, IL-35, and IL-10, contributes to apoptotic T-cell-mediated immunosuppression. Mechanistically, apoptotic T cells release and convert a large amount of ATP to adenosine via CD39 and CD73, and mediate immunosuppression via the adenosine and A pathways. Apoptosis in T cells is attributed to their weak NRF2-associated antioxidant system and high vulnerability to free oxygen species in the tumor microenvironment. Thus, the data support a model wherein tumor T cells sustain and amplify their suppressor capacity through inadvertent death via oxidative stress. This work highlights the oxidative pathway as a metabolic checkpoint that controls T cell behavior and affects the efficacy of therapeutics targeting cancer checkpoints.

摘要

存活的调节性T细胞(T细胞)会抑制抗肿瘤免疫,但T细胞在代谢异常的肿瘤微环境中的行为仍不清楚。在此,我们发现肿瘤T细胞会发生凋亡,且这种凋亡的T细胞会消除自发的以及PD-L1阻断介导的抗肿瘤T细胞免疫。生化和功能分析表明,促成凋亡T细胞介导的免疫抑制的是腺苷,而非PD-L1、CTLA-4、TGF-β、IL-35和IL-10等典型抑制因子。从机制上来说,凋亡的T细胞通过CD39和CD73释放并将大量ATP转化为腺苷,并通过腺苷和A通路介导免疫抑制。T细胞中的凋亡归因于其与NRF2相关的抗氧化系统较弱,以及在肿瘤微环境中对活性氧的高敏感性。因此,这些数据支持了一种模型,即肿瘤T细胞通过氧化应激导致的意外死亡来维持并增强其抑制能力。这项工作突出了氧化途径作为一个代谢检查点,它控制T细胞行为并影响靶向癌症检查点的治疗效果。

相似文献

1
Oxidative stress controls regulatory T cell apoptosis and suppressor activity and PD-L1-blockade resistance in tumor.
Nat Immunol. 2017 Dec;18(12):1332-1341. doi: 10.1038/ni.3868. Epub 2017 Oct 30.
2
Extracellular purine metabolism and signaling of CD73-derived adenosine in murine Treg and Teff cells.
Am J Physiol Cell Physiol. 2011 Aug;301(2):C530-9. doi: 10.1152/ajpcell.00385.2010. Epub 2011 May 18.
5
Ectonucleotidase CD73 and CD39 expression in non-small cell lung cancer relates to hypoxia and immunosuppressive pathways.
Life Sci. 2020 Oct 15;259:118389. doi: 10.1016/j.lfs.2020.118389. Epub 2020 Sep 6.
6
High-dimensional analysis of the adenosine pathway in high-grade serous ovarian cancer.
J Immunother Cancer. 2021 Mar;9(3). doi: 10.1136/jitc-2020-001965.
8
Autocrine Adenosine Regulates Tumor Polyfunctional CD73CD4 Effector T Cells Devoid of Immune Checkpoints.
Cancer Res. 2018 Jul 1;78(13):3604-3618. doi: 10.1158/0008-5472.CAN-17-2405. Epub 2018 Mar 20.
10
CXCR4 Inhibition Counteracts Immunosuppressive Properties of Metastatic NSCLC Stem Cells.
Front Immunol. 2020 Oct 2;11:02168. doi: 10.3389/fimmu.2020.02168. eCollection 2020.

引用本文的文献

1
Oxidative stress in cancer: from tumor and microenvironment remodeling to therapeutic frontiers.
Mol Cancer. 2025 Aug 22;24(1):219. doi: 10.1186/s12943-025-02375-x.
2
Mitochondria reactive oxygen species signaling-dependent immune responses in macrophages and T cells.
Immunity. 2025 Aug 12;58(8):1904-1921. doi: 10.1016/j.immuni.2025.07.012. Epub 2025 Aug 4.
4
Immunosuppressive mechanisms and therapeutic targeting of regulatory T cells in ovarian cancer.
Front Immunol. 2025 Jul 9;16:1631226. doi: 10.3389/fimmu.2025.1631226. eCollection 2025.
6
Mitochondrial unfolded protein response in regulatory T cell function: a protective mechanism in immune aging.
Front Immunol. 2025 Jun 30;16:1621759. doi: 10.3389/fimmu.2025.1621759. eCollection 2025.
7
Daurisoline Modulates the TBK1-Dependent Type I Interferon Pathway to Boost Anti-tumor Immunity via Targeting of LRP1.
Research (Wash D C). 2025 Jul 4;8:0764. doi: 10.34133/research.0764. eCollection 2025.
8
Insights from Clinical Trials on A Adenosine Receptor Antagonists for Cancer Treatment.
ACS Pharmacol Transl Sci. 2025 May 2;8(6):1498-1512. doi: 10.1021/acsptsci.5c00057. eCollection 2025 Jun 13.
9
The tumor microenvironment's role in the response to immune checkpoint blockade.
Nat Cancer. 2025 Jun 13. doi: 10.1038/s43018-025-00986-3.
10
Regulatory T cells in the tumour microenvironment.
Nat Rev Cancer. 2025 Jun 10. doi: 10.1038/s41568-025-00832-9.

本文引用的文献

1
Ionic immune suppression within the tumour microenvironment limits T cell effector function.
Nature. 2016 Sep 22;537(7621):539-543. doi: 10.1038/nature19364. Epub 2016 Sep 14.
2
A Distinct Gene Module for Dysfunction Uncoupled from Activation in Tumor-Infiltrating T Cells.
Cell. 2016 Sep 8;166(6):1500-1511.e9. doi: 10.1016/j.cell.2016.08.052.
3
Oxygen Sensing by T Cells Establishes an Immunologically Tolerant Metastatic Niche.
Cell. 2016 Aug 25;166(5):1117-1131.e14. doi: 10.1016/j.cell.2016.07.032.
4
Fundamentals of cancer metabolism.
Sci Adv. 2016 May 27;2(5):e1600200. doi: 10.1126/sciadv.1600200. eCollection 2016 May.
5
Effector T Cells Abrogate Stroma-Mediated Chemoresistance in Ovarian Cancer.
Cell. 2016 May 19;165(5):1092-1105. doi: 10.1016/j.cell.2016.04.009. Epub 2016 Apr 28.
6
Two FOXP3(+)CD4(+) T cell subpopulations distinctly control the prognosis of colorectal cancers.
Nat Med. 2016 Jun;22(6):679-84. doi: 10.1038/nm.4086. Epub 2016 Apr 25.
7
PD-L1 (B7-H1) and PD-1 pathway blockade for cancer therapy: Mechanisms, response biomarkers, and combinations.
Sci Transl Med. 2016 Mar 2;8(328):328rv4. doi: 10.1126/scitranslmed.aad7118.
8
Cancer mediates effector T cell dysfunction by targeting microRNAs and EZH2 via glycolysis restriction.
Nat Immunol. 2016 Jan;17(1):95-103. doi: 10.1038/ni.3313. Epub 2015 Nov 2.
9
Epigenetic silencing of TH1-type chemokines shapes tumour immunity and immunotherapy.
Nature. 2015 Nov 12;527(7577):249-53. doi: 10.1038/nature15520. Epub 2015 Oct 26.
10

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验